StockData

Indaptus Therapeutics, Inc. (INDP) stock

INDPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$3.17+0.02 (+0.63%)

Close on Nov 13, 2026Market cap $422.38MP/E –Yield –

Indaptus Therapeutics cash

Cash and short-term investments held at the end of each period.

Indaptus Therapeutics's cash was $30.60M at Sep 30, 2026. For fiscal 2025 it was $8.51M, up 47.0% from the year before. The highest annual figure on record is $39.13M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$8.51M+47.0%
FY2024Dec 31, 2024$5.79M-56.7%
FY2023Dec 31, 2023$13.36M-49.4%
FY2022Dec 31, 2022$26.43M-32.5%
FY2021Dec 31, 2021$39.13M+2289.8%
FY2020Dec 31, 2020$1.64M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$30.60M+425.3%
Q2 FY2026Jun 30, 2026$11.55M+87.6%
Q1 FY2026Mar 31, 2026$1.50M-61.5%
Q4 FY2025Dec 31, 2025$8.51M+47.0%
Q3 FY2025Sep 30, 2025$5.83M-21.1%
Q2 FY2025Jun 30, 2025$6.16M-15.7%
Q1 FY2025Mar 31, 2025$3.89M-60.1%
Q4 FY2024Dec 31, 2024$5.79M-56.7%
Q3 FY2024Sep 30, 2024$7.38M-53.8%
Q2 FY2024Jun 30, 2024$7.30M-62.9%
Q1 FY2024Mar 31, 2024$9.74M-55.1%
Q4 FY2023Dec 31, 2023$13.36M-49.4%
Q3 FY2023Sep 30, 2023$15.96M-43.9%
Q2 FY2023Jun 30, 2023$19.69M-40.3%
Q1 FY2023Mar 31, 2023$21.68M-40.1%
Q4 FY2022Dec 31, 2022$26.43M-32.5%
Q3 FY2022Sep 30, 2022$28.46M-32.0%
Q2 FY2022Jun 30, 2022$33.01M+94.3%
Q1 FY2022Mar 31, 2022$36.18M+2109.3%
Q4 FY2021Dec 31, 2021$39.13M+183.6%
Q3 FY2021Sep 30, 2021$41.86M–
Q2 FY2021Jun 30, 2021$16.99M–
Q4 FY2020Dec 31, 2020$1.64M–
Q2 FY2020Jun 30, 2020$13.80M–

More Indaptus Therapeutics figures

See a number that looks wrong?